↓ Skip to main content

Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016

Overview of attention for article published in Vaccine, July 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
52 Mendeley
Title
Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016
Published in
Vaccine, July 2020
DOI 10.1016/j.vaccine.2020.07.039
Pubmed ID
Authors

Tanya R Myers, Michael M McNeil, Carmen S Ng, Rongxia Li, Paige L Marquez, Pedro L Moro, Saad B Omer, Maria V Cano

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 52 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 21%
Student > Master 6 12%
Researcher 5 10%
Student > Ph. D. Student 3 6%
Student > Doctoral Student 2 4%
Other 5 10%
Unknown 20 38%
Readers by discipline Count As %
Medicine and Dentistry 14 27%
Nursing and Health Professions 4 8%
Immunology and Microbiology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Computer Science 2 4%
Other 6 12%
Unknown 22 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2023.
All research outputs
#7,966,302
of 25,387,668 outputs
Outputs from Vaccine
#7,832
of 16,513 outputs
Outputs of similar age
#167,145
of 426,494 outputs
Outputs of similar age from Vaccine
#77
of 164 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 16,513 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,494 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.